Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Net Income: 2010-2024

Historic Net Income for SRx Health Solutions (SRXH) over the last 14 years, with FY2024 value amounting to $4.2 million.

  • SRx Health Solutions' Net Income fell 52783.58% to -$16.8 million in Q2 2025 from the same period last year, while for Sep 2025 it was -$9.3 million, marking a year-over-year increase of 5030.79%. This contributed to the annual value of $4.2 million for FY2024, which is 11841.02% up from last year.
  • Per SRx Health Solutions' latest filing, its Net Income stood at $4.2 million for FY2024, which was up 11841.02% from -$22.8 million recorded in FY2023.
  • In the past 5 years, SRx Health Solutions' Net Income ranged from a high of $4.2 million in FY2024 and a low of -$59.3 million during FY2020
  • Its 5-year average for Net Income is -$22.8 million, with a median of -$22.8 million in 2023.
  • Its Net Income has fluctuated over the past 5 years, first tumbled by 126079.13% in 2022, then soared by 11841.02% in 2024.
  • SRx Health Solutions' Net Income (Annual) stood at -$59.3 million in 2020, then soared by 105.71% to $3.4 million in 2021, then plummeted by 1260.79% to -$39.3 million in 2022, then soared by 42.08% to -$22.8 million in 2023, then skyrocketed by 118.41% to $4.2 million in 2024.
  • Its Net Income stands at $4.2 million for FY2024, versus -$22.8 million for FY2023 and -$39.3 million for FY2022.